Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of AJG511 (budesonide) in patients with active ulcerative colitis
jRCT2080222653Phase 3
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in autoimmune colitis comparing AJG511 (budesonide) intrarectal with Placebo intrarectal (2 arms).
02
Drugs
budesonide
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2080222653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222653.